Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-18

Clinical Trial Update: Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated quetiapine versus placebo for preventing relapse in individuals with alcohol use disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Conditions: Alcohol Relapse Prevention, Alcoholism | Phase 2 | Status: COMPLETED